Iclusig (ponatinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iclusig (ponatinib), covering 2024-12-31 to 2024-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP) [Phase 2]